Product guides
Alpha-lipoic acid for neuropathy
It is the one supplement in this category with trial evidence worth taking seriously — and the evidence is more mixed, and more specific about form and dose, than the bottle suggests.
Written by the Managing Neuropathy editorial team under the direction of Dr. Tom Biernacki, DPM, FACFAS · Clinical review pending · Last updated 6 September 2026
The short answer. Alpha-lipoic acid has been studied in painful diabetic neuropathy, mostly at 600 mg per day, with the strongest results coming from intravenous courses that are not what you can buy. Oral results are more modest and less consistent, and the effect measured is symptom relief, not nerve repair. The safety point that matters: it can lower blood glucose, which is a real consideration if you take insulin or a sulfonylurea.
What it is
Alpha-lipoic acid is a compound the body makes itself and uses in energy metabolism. It behaves as an antioxidant and is unusual in being active in both watery and fatty environments, which is the property most often cited as the reason it might help nerves. In Germany it has been used as a prescribed treatment for diabetic neuropathy; in the United States it is sold as a dietary supplement, which means nothing about it is reviewed for effectiveness before it reaches a shelf.
What the evidence actually shows
This is the rare supplement with real randomised trials behind it, so it is worth being precise about what they found.
Intravenous courses show the clearest benefit. The best-known trials gave 600 mg intravenously daily for around three weeks and reported meaningful reductions in burning, pain and numbness compared with placebo. This is the strongest part of the evidence base — and it is delivered by infusion, not by a capsule.
Oral results are weaker and less consistent. Several oral trials at 600 mg daily have reported symptom improvement over a few weeks. The longest and most rigorous study, running four years, did not meet its primary endpoint, though some secondary measures moved. A fair summary is: possible modest symptom benefit for some people, not established, and nowhere near the confidence you would expect from the packaging.
It is a symptom treatment, not a repair. Even the positive studies measured how people felt, not how many nerve fibers they had. Nothing here supports the regeneration language used to sell it. Why that language keeps working is here.
The dose that was studied
Trials converge on 600 mg per day for oral use. Higher doses — 1,200 and 1,800 mg have both been tested — did not perform better and produced more nausea and stomach upset. That is worth knowing when you see a product boasting a bigger number, because in this case the bigger number is not the better one.
Two practical details from the trial literature. Absorption is reduced when it is taken with food, so studies typically dosed it on an empty stomach, around half an hour before eating. And most trials used the racemic mixture — the ordinary form — rather than the more expensive R-isomer products, so the premium form is the one with less direct trial evidence, not more.
None of this is a recommendation to take a dose. It is what the studies used, so that you can have an accurate conversation with the clinician or pharmacist who knows your medicines.
The safety point no retailer prints
Alpha-lipoic acid can lower blood glucose. The people most likely to buy it are people with diabetic neuropathy — that is, people with diabetes, many of whom take insulin or a sulfonylurea. Adding something that lowers glucose on top of a medicine that lowers glucose is how hypoglycaemia happens. If you take either, this is a conversation to have before the first capsule, not after the first episode.
Three further cautions belong on the label and usually are not:
- Thyroid medication. Alpha-lipoic acid may interfere with thyroid hormone; if you take levothyroxine, ask about separating them or monitoring.
- A rare autoimmune hypoglycaemia. Insulin autoimmune syndrome has been reported in association with alpha-lipoic acid, predominantly in people of East Asian ancestry carrying a particular tissue type. It is rare, and it is real.
- Stomach upset and rash are the ordinary reasons people stop, and are dose-related.
It also interacts with the wider picture: if your neuropathy has never been investigated, a supplement is standing in for a diagnosis. The tests worth asking for are here.
How to read a label in this category
And check how many capsules a serving is. 600 mg is the studied figure; more is not better.
Alpha-lipoic acid is frequently sold inside “nerve support” blends carrying high-dose B6, which causes neuropathy. This is the most important single check on the bottle. Why, in detail.
Supplements are not verified for content before sale. A verification mark from an independent laboratory is one of the few meaningful signals available.
Neither phrase has a regulatory meaning.
The trials measured symptoms. A seller claiming more than their own evidence supports is telling you something useful about themselves.
Where it sits against the alternatives
| Option | Strength of evidence |
|---|---|
| Treating the cause — glucose control, correcting B12, reducing alcohol | Strongest. The only category that slows the damage. |
| Prescription nerve-pain medicines | Strong for symptom reduction, with approvals specifically for diabetic nerve pain. |
| Alpha-lipoic acid | Mixed. Best evidence intravenous; oral modest and inconsistent. |
| B vitamins without a deficiency | No good evidence, and high-dose B6 causes harm. |
| Most other “nerve support” blends | No meaningful evidence in humans with neuropathy. |
Judged fairly, alpha-lipoic acid is a reasonable thing to ask your clinician about once the causes have been investigated and the pain is being treated properly. It is a poor substitute for either. The full treatment picture is here.
Specific product recommendations
Picks in this category are judged on dose accuracy, independent third-party testing, and whether the rest of the formula is free of high-dose B6 — not on commission. Our editorial policy requires that we be able to state what was assessed and how before recommending anything by name, so that is set out below.
Our pick: Nutricost Alpha-Lipoic Acid, 600 mg per serving
Assessed against those three criteria. Here is what each one returned, so you can disagree with the reasoning rather than take the pick on trust.
Dose accuracy. 600 mg in a single serving, which is the dose the trials described above actually used — not a proprietary blend, and not a 100 mg capsule you would need six of. It is also plain alpha-lipoic acid, meaning the racemic form those trials used rather than the more expensive R-isomer. That is deliberate: as this page says above, the premium form is the one with less direct trial evidence, not more.
Independent third-party testing. The manufacturer states third-party testing and manufacture in a GMP-compliant, FDA-registered facility. We have read that claim; we have not run our own assay, and we would rather say so than imply more than we know.
No high-dose B6 in the formula. There is no pyridoxine in it. That matters more than it sounds, because high-dose B6 is itself a cause of peripheral neuropathy and it turns up in a great many combination “nerve support” products. We also checked what the listing sells alongside it, after a B12 product assessed for this site turned out to put a 100 mg B6 tablet one click away. This one does not.
What it does not do. It does not treat the cause of your neuropathy, and it is not a reason to delay finding out what that cause is. Everything this page says above about realistic expectations still applies.
Check the current price on Amazon →
Affiliate relationship: some links on this page are affiliate links and we may earn a commission from qualifying purchases at no additional cost to you. As an Amazon Associate I earn from qualifying purchases. See our affiliate disclosure.
Common questions
How long before I would know if it works?
Oral trials generally ran for several weeks before measuring. If you and your clinician decide to try it, judge it over weeks rather than days — and remember that symptoms fluctuate on their own, which is what makes short trials of anything so misleading.
Is R-lipoic acid better?
It is the biologically active form and is absorbed better, which is the argument for the premium price. Most of the trial evidence used the ordinary racemic form, so the better-absorbed version is also the less-studied one.
Can I take it with my nerve pain medication?
That is a question for your pharmacist, who can see everything you take. The glucose-lowering effect is the interaction most likely to matter.
Will it reverse my neuropathy?
No. The trials measured symptoms, not nerve fibers. Anything claiming regeneration is claiming more than the evidence supports.
Related reading
Supplements for neuropathy, in full · What treatment actually does · The seven-day claim · Home remedies · Neuropathy in the feet
Sources and further reading: Randomised trials of alpha-lipoic acid in symptomatic diabetic polyneuropathy, including the intravenous ALADIN program, the oral SYDNEY 2 trial and the four-year NATHAN 1 trial. American Diabetes Association Standards of Care, neuropathy section. National Institutes of Health Office of Dietary Supplements, vitamin B6 tolerable upper intake level. US Food and Drug Administration, dietary supplement regulation.
This page is general education and is not a diagnosis, a treatment plan, or advice to start or stop any medicine. Clinical review by Dr. Biernacki is pending; the review date will be shown here once complete.
For our Michigan neighbors
Worth asking before
you spend on capsules.
An examination and the right blood tests answer more than a supplement will, particularly if nobody has established your cause. Dr. Biernacki’s Michigan practice can do that.
Everywhere else, take this page to your own clinician.
Dr. Tom Biernacki, DPM, FACFAS is a double board-certified foot and ankle surgeon (ABFAS and ABPM) and a Fellow of the American College of Foot & Ankle Surgeons. He is the founder of Balance Foot & Ankle in Howell and Bloomfield Township, Michigan, where peripheral neuropathy, diabetic foot risk and loss of protective sensation are part of his weekly clinic. His patient education videos have drawn more than 950,000 subscribers on YouTube. He writes Managing Neuropathy to put the explanation he gives in the exam room in front of the people who cannot get to one — including when a product is worth buying and when it is not.